1. 1. Ko, K.S., Lee, M.Y., Song, J.H., et al. (2008): Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn. Microbiol. Infect. Dis., 61, 453–459.
2. 2. Potz, N.A., Hope, R., Warner, M., et al. (2006): Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J. Antimicrob. Chemother., 58, 320–326.
3. 3. Schlesinger, J., Navon-Venezia, S., Chmelnitsky, I., et al. (2005): Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel. Antimicrob. Agents Chemother., 49, 1150–1156.
4. 5. Kaczmarek, F.M., Dib-Hajj, F., Shang, W., et al. (2006): High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoE. Antimicrob. Agents Chemother., 50, 3396–3406.
5. 6. Oteo, J., Delgado-Iribarren, A., Vega, D., et al. (2008): Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int. J. Antimicrob. Agents, 32, 534–537.